pre-update Archives

On-Demand Webinar

Smarter Clinical Document Automation for Transparency and Disclosure Requirements

Transparency and disclosure efforts are an integral part of medical writing for submissions. Sponsors receive…

CertaraApril 14, 2022

Blog

5 Reasons Why You Should Use Phoenix WinNonlin for PK/PD Analyses

Pharmaceutical companies around the globe face the challenge of increasingly longer drug development cycles and…

CertaraMarch 25, 2022

Fact Sheet

SEND Explorer – Product Family

Discover how SEND Explorer transforms nonclinical data analysis.

CertaraMarch 23, 2022

On-Demand Webinar

eChalk Talk: How Oncology Drug Developers Can Prepare for FDA’s Project Optimus

Historically, the dosing strategy for oncology drugs has focused on use of the maximum tolerated…

CertaraMarch 22, 2022

Video

The Value of BaseCase

CertaraMarch 21, 2022

Announcement

Certara Selected by the European Medicines Agency to Provide Real World Solutions for Critical Regulatory Decisions

Princeton, N.J., March 17, 2022 -- Certara, Inc. today announced a four-year, framework service contract…

CertaraMarch 17, 2022

Blog

How to Fix Your Biggest Bioequivalence Mistakes

Bioequivalence is a commonly misunderstood term within biopharmaceutics. For starters, bioequivalence is a technical term…

CertaraMarch 16, 2022

Blog

Experts Unravel the Top 5 Myths Related to Bioequivalence

Bioequivalence enables bridging safety and effectiveness of oral pharmaceutical dosage forms using pharmacokinetics. The concepts…

CertaraFebruary 18, 2022

Press Coverage

The Challenging Road to Developing an Integrated Platform for Drug Discovery and Precision Medicine Using the Power of Pharmacometrics

We have often seen Dr. Hwi-yeol (Thomas) Yun, Associate Professor/Adjunct Professor at the College of…

CertaraFebruary 7, 2022

On-Demand Webinar

Improved Workflow and Expanded functionality of RsNLME v1.1

R Speaks NLME (RsNLME) is a collection of R packages and companion RShiny apps that…

CertaraJanuary 31, 2022

pre-update

Smarter Clinical Document Automation for Transparency and Disclosure Requirements

5 Reasons Why You Should Use Phoenix WinNonlin for PK/PD Analyses

SEND Explorer – Product Family

eChalk Talk: How Oncology Drug Developers Can Prepare for FDA’s Project Optimus

The Value of BaseCase

Certara Selected by the European Medicines Agency to Provide Real World Solutions for Critical Regulatory Decisions

How to Fix Your Biggest Bioequivalence Mistakes

Experts Unravel the Top 5 Myths Related to Bioequivalence

The Challenging Road to Developing an Integrated Platform for Drug Discovery and Precision Medicine Using the Power of Pharmacometrics

Improved Workflow and Expanded functionality of RsNLME v1.1

Newsletter sign up

Quick links

Solutions

Contact